New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 15, 2013
07:21 EDTPCYCPharmacyclics price target raised to $90 from 79 at Credit Suisse
Credit Suisse believes Pharmacyclics shares will be driven by a faster path to market for ibrutinib, rapid adoption, and data flow in 2013/2014. Shares are Outperform rated.
News For PCYC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 16, 2015
15:31 EDTPCYCPharmacyclics resumes, up 0.6% to $256.58 after HELIOS hits primary endpoint
Subscribe for More Information
15:08 EDTPCYCPharmacyclics to resume trading at 3:30 pm EDT
Subscribe for More Information
15:04 EDTPCYCPharmacyclics says committee recommends unblinding after primary endpoint met
Subscribe for More Information
14:55 EDTPCYCPharmacyclics trading halted, pending news

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use